Influence of dietary sodium on the blood pressure and renal sympathetic nerve activity responses to intracerebroventricular angiotensin II and angiotensin III in anaesthetized rats: Experimental Physiology-Research Paper

Experimental Physiology

Volumn 95, Issue 2, 2010, Pages 282-295

  Houghton, Belinda L ^a,b   Huang, Chunlong ^a   Johns, Edward J ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN III; CHLORALOSE; SODIUM; URETHAN; VASOPRESSIN V1 RECEPTOR;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; KIDNEY INNERVATION; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; RAT; RECEPTOR BLOCKING; SODIUM INTAKE; SYMPATHETIC NERVE; TREATMENT RESPONSE;

EID: 75149149916     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2009.049833     Document Type: Article

References (39)

1. Antunes VR, Yao ST, Pickering AE, Murphy D Paton JFR (2006). A spinal vasopressinergic mechanism mediates hyperosmolality-induced sympathoexcitation. J Physiol 576, 569 583.
2. Brooks VL, Freeman KL Qi Y (2006). Time course of synergistic interaction between DOCA and salt on blood pressure: roles of vasopressin and hepatic osmoreceptors. Am J Physiol Regul Integr Comp Physiol 291, R1825 R1834.
3. Carillo BA, Beutel A, Mirandola DA, Vidonho AF Jr., Furukawa LN, Casarini D, Campos RR, Dolnikoff MS, Heimann JC Bergamaschi CT (2007). Differential sympathetic and angiotensinergic responses in rats submitted to low-or high-salt diet. Regul Pept 140, 5 11.
4. Costa-E-Sousa RH, Pereira-Junior PP, Oliveira PF, Olivares EL, Werneck-de-Castro JP, Mello DB, Nascimento JH Campos-de-Carvalho AC (2005). Cardiac effects of oxytocin: is there a role for this peptide in cardiovascular homeostasis? Regul Pept 15, 107 112.
5. Cowley AW, Skelton MM, Merrill DC, Quillen EW Switzer SJ (1983). Influence of daily sodium intake on vasopressin secretion and drinking in dogs. Am J Physiol Regul Integr Comp Physiol 245, R860 R872.
6. Ferris CF, Lu SF, Messenger T, Guillon CD, Heindel N, Miller M, Koppel G, Bruns RF Simon NG (2006). Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior. Pharmacol Biochem Behav 83, 169 174.
7. Fournie-Zaluski MC, Fassott C, Valentin B, Djordjijevic D, Reaux-Le Goazigo A, Corvol P, Roques B Llorens-Cortes C (2004). Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc Natl Acad Sci USA 101, 7775 7780.
8. Fujio T, Fujihara H, Shibata M, Yamada S, Onaka T, Tanaka K, Morita H, Dayanitihi G, Kawata M, Murphy D Ueta Y (2006). Exaggerated response of arginine vasopressin-enhanced green flourescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats. J Neuroendocrinol 18, 776 785.
9. Habecker BA, Grygielko ET, Huhtala TA, Foote B Brooks VL (2003). Ganglionic tyrosine hydroxylase and norepinephrine transporter are decreased by increased sodium chloride in vivo and in vitro. Auton Neurosci 107, 85 98.
10. 125I]angiotensins in rat. J Neurochem 46, 1292 1297.
11. Huang BS Leenen FH (1992). Dietary Na, age, and baroreflex control of heart rate and renal sympathetic nerve activity in rats. Am J Physiol Heart Circ Physiol 262, H1411 H1448.
12. Huang BS Leenen FH (1994). Dietary Na and baroreflex modulation of blood pressure and RSNA in normotensive vs. spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 266, H496 H502.
13. Huang C Johns EJ (2001). Role of brain angiotensin II on somatosensory-induced antinatriuresis in hypertensive rats. Hypertension 37, 1369 1374.
14. Huang C, Yoshimoto M, Miki K Johns EJ (2006). The contribution of brain angiotensin II to the baroreflex regulation of renal sympathetic nerve activity in conscious normotensive and hypertensive rats. J Physiol 574, 597 604.
15. Jo H, Yang EK, Lee WJ, Park KY, Kim HJ Park JS (1996). Gene expression of central and peripheral renin-angiotensin system components upon dietary sodium intake in rats. Regul Pept 67, 115 121.
16. Kruszynski M, Lammek B, Manning M, Seto J, Haldar J Sawyer WH (1980). [1-β-Mercapto-β,β-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-β-mercapto-β, β-cyclopentamethylenepropionic acid)]arginine-vasopressin, two high potent antagonists of the vasopressor response to arginine-vasopressin. J Med Chem 23, 364 368.
17. Kubo T Hagiwara Y (2006). Angiotensin II sensitivity of anterior hypothalamic area neurons is enhanced in both spontaneously hypertensive rats and Dahl salt-sensitive rats. Neurosci Lett 397, 297 300.
18. Landgraf R, Malkinson T, Horn T, Veale W, Lederis K Pittman Q (1990). Release of vasopressin and oxytocin by paraventricular stimulation in rats. Am J Physiol Regul Integr Comp Physiol 258, R155 R159.
19. Loń S, Szczepańska-Sadowska E Szczypaczewska M (1996). Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II. Am J Physiol Heart Circ Physiol 270, H167 H173.
20. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FAO Chai SY (2003). The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35, 901 918.
21. May CN (1996). Prolonged systemic and regional haemodynamic effects of intracerebroventricular angiotensin II in conscious sheep. Clin Exp Pharmacol Physiol 23, 878 884.
22. May CN, McAllen RM McKinley MJ (2000). Renal nerve inhibition by central NaCl and ANG II is abolished by lesions of the lamina terminalis. Am J Physiol Regul Integr Comp Physiol 279, R1827 R1833.
23. O'Donaughy T Brooks V (2006). Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels. Hypertension 47, 680 685.
24. Paxinos G Watson C (2005). The Rat Brain in Stereotaxic Coordinates, fifth edn. Elsevier, London.
25. Qadri F, Culman J, Veltmar A, Maas K, Rascher W Unger T (1993). Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 267, 567 574.
26. Ramchandra R, Barrett CJ, Guild SJ, McBryde F Malpas SC (2005). Role of renal sympathetic nerve activity in hypertension induced by chronic nitric oxide inhibition. Am J Physiol Regul Integr Comp Physiol 292, R1479 R1485.
27. Reaux A, Fournie-Zaluski MC Llorens-Cortes C (2001). Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol Metab 12, 157 162.
28. Reaux A, Iturrioz X, Vazuex G, Fournie-Zaluski MC, David C, Roques BP, Corvol P Llorens-Cortes C (2000). Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem Soc Trans 28, 435 440.
29. 1 receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol 33, 690 695.
30. 1 receptor regulation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 46, H1701 H1707.
31. Swenson SJ, Speth RC Porter JP (2004). Effect of a perinatal high-salt diet on blood pressure control mechanisms in young Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 286, R764 R770.
32. Vandesande F Dierickx K (1975). Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat. Cell Tissue Res 164, 153 162.
33. 1 receptor densities in Dahl rats. Am J Physiol Heart Circ Physiol 285, H1949 H1955.
34. Watson AM, Mogulkoc R, McAllen RM May CN (2004). Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep. Am J Physiol Regul Integr Comp Physiol 286, R1051 R1056.
35. Wright JW, Tamura-Meyers E, Wilson WL, Roques BP, Llorens-Cortes C, Apeth RC Harding JW (2003). Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. Am J Physiol Regul Integr Comp Physiol 284, R725 R733.
36. Yang Z Coote JH (2006). The role of supraspinal vasopressin and glutamate neurones in an increase in renal sympathetic activity in response to mild haemorrhage in the rat. Exp Physiol 91, 791 797.
37. Yang Z, Wheatley M Coote JH (2002). Neuropeptides, amines, and amino acids as mediators of the sympathetic effects of paraventricular nucleus activation in the rat. Exp Physiol 87, 663 674.
38. Zini S, Demassey Y, Fournie-Zaluski MC, Bischoff L, Corvol P, Llorens-Cortes C Sanderson P (1998). Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor. Neuroreport 9, 825 828.
39. Zini S, Fournie-Zaluski MC, Chauvel E, Roques BP, Corvol P Llorens-Cortes C (1996). Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93, 11968 11973.